| http://www.w3.org/ns/prov#value | - The development of resistance to the actives mentioned hereinbefore may be monitored by means of testing for presence of a mutation associated with resistance to the respective active in circulating tumor cells obtained from the circulation, or other bodily fluid, of the subject.
|
